Design, synthesis, and in vitro antitumor evaluation of novel benzimidazole acylhydrazone derivatives
Molecular Diversity · 2025
DOI: 10.1007/s11030-024-11064-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Lihui Shao und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Benzimidazoles, Drug Design, Hydrazones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Foundation for Excellent Scholars Program, Natural Science Foundation of Guizhou Province.
Abstract (Originalsprache)
This study focuses on the design, synthesis, and evaluation of benzimidazole derivatives for their anti-tumor activity against A549 and PC-3 cells. Initial screening using the MTT assay identified compound 5m as the most potent inhibitor of A549 cells with an IC50 of 7.19 μM, which was superior to the positive agents 5-Fluorouracil and Gefitinib. Cellular mechanism studies elucidated 5m arrests cell cycle at G2/M phase, induces apoptosis along with the decrease of mitochondrial membrane potential and increased reactive oxygen species. Colony formation and wound healing assays demonstrated that 5m markedly inhibited the clonogenic and migratory abilities of A549 cells. Western blot analysis showed an upregulation of pro-apoptotic protein Bax, downregulation of anti-apoptotic protein Bcl-2, and significant downregulation of cell cycle proteins CyclinB1 and CDK-1. These findings suggest that compound 5m effectively suppresses A549 cell proliferation and migration through multiple mechanisms, highlighting its potential as a novel anti-lung cancer agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals of Guizhou University, Guiyang, Guizhou, 550025, People…
- College of Pharmacy, Guizhou Engineering Laboratory for Synthetic Drugs, Guizhou University, Guiyang, Guizhou, 550025, People's Republic of China.
- School of Chemistry and Chemical Engineering, Guizhou University, Guiyang, Guizhou, 550025, People's Republic of China.
- College of Pharmacy, Guizhou Engineering Laboratory for Synthetic Drugs, Guizhou University, Guiyang, Guizhou, 550025, People's Republic of China. 1056878529@qq.com.
- College of Pharmacy, Guizhou Engineering Laboratory for Synthetic Drugs, Guizhou University, Guiyang, Guizhou, 550025, People's Republic of China. zcwang@gzu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Guizhou Provincial Foundation for Excellent Scholars Program
- Natural Science Foundation of Guizhou Province
- Guizhou Provincial Young Science and Technology Talents Development Project
- National Key Research and Development Program of China
Zitieren
APA
Shao, L., Feng, N., Zhou, Y., Li, C., Chen, D., Li, C., Zhou, X., Li, Z., & Wang, Z. (2025). Design, synthesis, and in vitro antitumor evaluation of novel benzimidazole acylhydrazone derivatives. Molecular Diversity. https://doi.org/10.1007/s11030-024-11064-8
Vancouver
Shao L, Feng N, Zhou Y, Li C, Chen D, Li C, et al. Design, synthesis, and in vitro antitumor evaluation of novel benzimidazole acylhydrazone derivatives. Molecular Diversity. 2025. doi:10.1007/s11030-024-11064-8
BibTeX
@article{Shao2025,
author = {Shao, Lihui and Feng, Nianlin and Zhou, Yue and Li, Chengpeng and Chen, Danping and Li, Chenchen and Zhou, Xiang and Li, Zhurui and Wang, Zhenchao},
title = {Design, synthesis, and in vitro antitumor evaluation of novel benzimidazole acylhydrazone derivatives},
journal = {Molecular Diversity},
year = {2025},
doi = {10.1007/s11030-024-11064-8}
}
EUVIMED